News Conference News ACC 2026 ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Conference News CRT 2026 AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis L.A. McKeown March 11, 2026
News Daily News HBR Common, Impactful Among All-Comer Acute MI Patients Yael L. Maxwell March 05, 2026
News Conference News EAPCI 2026 SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry Caitlin E. Cox February 27, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2026 Caitlin E. Cox February 02, 2026
News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2025 Caitlin E. Cox December 01, 2025
News Conference News AHA 2025 Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD Todd Neale November 13, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Conference News TCT 2025 Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE Caitlin E. Cox October 28, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Conference News ESC 2025 DAPT’s Role After CABG Questioned: TACSI and TOP-CABG Caitlin E. Cox September 05, 2025
Presentation ESC 2025 Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial Presenter: David Newby September 03, 2025
Presentation ESC 2025 Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial Presenter: Anders Jeppsson September 01, 2025
News Conference News ESC 2025 AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC Todd Neale September 01, 2025
Presentation ESC 2025 PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial Presenter: Pedro A. Lemos August 30, 2025